ADVFN Logo
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Adaptimmune Therapeutics PLC

Adaptimmune Therapeutics PLC (ADAP)

0.5788
-0.0092
(-1.56%)
Closed December 26 4:00PM
0.5788
0.00
(0.00%)
After Hours: 4:59PM

Income Statement

Balance Sheet

Cash Flow

Quarter End Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 11.03M47.6M5.13M7.32M231k5.68M128.23M40.9M
Operating Income -27.18M1.55M-22.94M-46.3M-28.32M-49.02M68.57M-11.25M
Pre Tax Income -28.26M1.66M-20.71M-44.91M-48.57M-47.98M70.05M-16.79M
Net Income -29.25M1.04M-21.39M-45.6M-47.92M-48.5M69.52M-17.62M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 00000000
EBIT -28.72M1.55M-23.11M-46.63M-28.63M-49.02M68.57M-13.91M
EBITDA -25.74M3.39M-20.71M-43.41M-25.45M-46.19M71.31M-8.43M
Year End December 30 2023 20162017201820192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 14.2M37.83M59.51M1.12M3.96M6.15M27.15M60.28M
Operating Income -75.77M-86.35M-98.61M-138.62M-133.58M-157.85M-166.4M-118.3M
Pre Tax Income -73.78M-80.45M-107.72M-136.92M-129.93M-157.3M-162.96M-112.54M
Net Income -68.8M-71.31M-91.56M-137.17M-130.09M-158.09M-165.46M-113.87M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) -0.162-0.127-0.146-0.217-0.14-0.169-0.168-0.084
EBIT -75.89M-86.54M-98.62M-138.62M-133.58M-157.85M-166.4M-118.3M
EBITDA -72.48M-80.93M-90.8M-130.61M-125.98M-151.29M-160.33M-108.46M

Your Recent History

Delayed Upgrade Clock